J S Kenney

Hôpitaux Universitaires de Strasbourg — France

Immunology and Microbiology · Life Sciences

11h-index3.0kcitations12works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Response and Inflammation(6), Sepsis Diagnosis and Treatment(4), Vitamin C and Antioxidants Research(3), Inflammatory Bowel Disease(2), Burn Injury Management and Outcomes(2)

Publications12 total

In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
Gut·1997· 77 citedOpen Access
Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.
Gut·1996· 300 citedOpen Access
A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon.
The Journal of Experimental Medicine·1996· 56 citedOpen Access
PEG-BP-30 Monotherapy Attenuates the Cytokine-Mediated Inflammatory Cascade in Baboon Escherichia coli Septic Shock
Journal of Surgical Research·1995· 46 citedOpen Access
Die Endotoxin-induzierte Synthese und Sekretion von Interleukin-1β und Interleukin-6 in humanem Vollblut erfolgt unabhängig von Tumor-Nekrosefaktor-α
1994· 1 cited
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
Blood·1992· 211 citedOpen Access
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease
Blood·1992· 20 citedOpen Access
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.
Journal of Clinical Investigation·1992· 334 citedOpen Access
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Journal of Clinical Investigation·1992· 650 citedOpen Access
IL-8 in septic shock, endotoxemia, and after IL-1 administration
The Journal of Immunology·1991· 308 cited
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.
Journal of Clinical Investigation·1990· 368 citedOpen Access
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
The Journal of Experimental Medicine·1989· 644 citedOpen Access

Frequent Co-authors

Lyle L. Moldawer(7), E Fischer(5), S. F. Lowry(3), Michael A. Marano(3), Yuman Fong(2), A. C. Allison(2), Kimberly J. Van Zee(2), Laura DeForge(2), Daniel G. Remick(2), S F Lowry(2), J.M. Reimund(2), Serge Dumont(2), Christian D. Muller(2), René Baumann(2), Philippe Poindron(2), Bernard Duclos(2), KJ Van Zee(2), MA Marano(2), CS Rock(2), DD Poutsiaka(2)